🇺🇸 Palvella Therapeutics, Inc.
Forum topic · PVLA · Company page: financials, ownership and filings
Join the discussion on Palvella Therapeutics, Inc.
Loading…
Results announced on 5 November 2026
Palvella Therapeutics, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $25 million.
Insider trading in October 2026
Directors and officers of Palvella Therapeutics, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $4,116,784 in 20 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 163 funds hold $694 million
163 mutual funds in 1 country hold shares of Palvella Therapeutics, Inc. worth $694 million, about 32.9% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 107 funds added shares and 29 sold; on balance they bought $131 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.